A small priming dose of rocuronium can shorten the onset time of neuromuscular blockade. Induction agents with less cardiovascular depression also reduce the onset time. We hypothesized that ketamine, compared to thiopentone, would reduce onset time and improve intubating conditions following priming. Sixty patients ASA I to II, randomized by computer-generated sequence to four groups were investigated in a double-blind controlled trial. In the two groups with priming, 0.04 mg/kg of rocuronium was followed by three minutes of priming interval. Induction was followed by an intubation dose of 0.4 mg/kg of rocuronium. After 30 seconds, intubation was attempted within a further 20 seconds. In the two control groups, the same sequence was repeated except sham priming (saline) was given. For induction, S-ketamine (1 mg/kg) or thiopentone (4 mg/kg) were administered. Intubating conditions were graded as excellent, good, poor, or not possible. Neuromuscular transmission was monitored by acceleromyography of the thumb. There were no measured differences in onset time of neuromuscular block or in haemodynamics between the groups. The proportion of good to excellent intubating conditions was higher when ketamine was preceded by priming compared to ketamine without priming (87% vs 20%; P<0.05). In both priming and control groups intubating conditions were improved when using ketamine compared to thiopentone (P<0.05). The mechanism of this effect was not clear from this study.
The potential side-effects of succinylcholine have raised increasing interest in a nondepolarizing neuromuscular blocking agent with a rapid onset of action such as rocuronium 1 . Intubating conditions at 90 seconds progressively improve when increasing the dose of rocuronium from 1.5 ED 95 (0.45 mg/kg) to 4 ED 95 (1.2 mg/kg) 2 . These large doses required if rocuronium is to be an alternative to succinylcholine for rapid sequence induction 3 have a prolonged duration of action 4 .
The onset time of nondepolarizing neuromuscular blocking agents can be shortened by priming. This consists of the administration of a small, subparalysing dose of neuromuscular blocking drug several minutes before a larger intubating dose 5 . Priming with rocuronium improves the onset time when compared to a single intubating dose of rocuronium 6 .
Among the factors influencing onset time is the rapidity with which neuromuscular blockers are delivered to the neuromuscular junction cleft. This time interval appears to be inversely proportional to cardiac output and muscle blood flow 7 . Induction agents that maintain cardiac output and blood pressure may promote a faster delivery of the neuromuscular blocking agent to the site of action 8, 9 . Ketamine has been shown to improve intubating conditions when used in association with rocuronium 8 .
Ketamine is a racemic mixture of two stereoisomers, Rand S + . Studies in healthy volunteers have shown that the haemodynamic and metabolic effects of the stereoisomers is comparable. S-ketamine is about twice as potent in terms of anaesthesia and is associated with a faster recovery 10 .
We investigated whether the combination of S-ketamine and priming would result in a further improvement in intubating conditions. A relatively low dose of rocuronium following priming was selected to improve sensitivity to the possible effect of ketamine (i.e. a high dose of rocuronium would work quickly irrespective of induction agent or priming). We hypothesized that S-ketamine would improve intubating conditions following a priming dose of 0.04 mg/kg and an intubating dose of 0.40 mg/kg of rocuronium compared with those achieved without priming and in comparison to the use of thiopentone for anaesthesia.
MATERIAL AND METHODS
Approval from the institutional Ethics Committee and the patients' written informed consent for the study were obtained. Sixty patients ASA I to II, aged 18 to 65 years, scheduled for elective surgery were investigated. Exclusion criteria included patients with anticipated difficult airways, medications known to interact with neuromuscular agents, obesity, evidence of neuromuscular, cardiovascular, respiratory, hepatic, or renal disease.
Patients were premedicated with midazolam 0.05 mg/kg 15 minutes before induction. On arrival in the operating room, ECG electrodes were applied and haemoglobin oxygen saturation was monitored by pulse oximetry. Blood pressure was measured noninvasively, and an intravenous infusion of Ringer's acetate solution 5 mg/kg/hour commenced into the antecubital vein of the contralateral arm.
Neuromuscular transmission was monitored using acceleromyography of the adductor pollicis muscle (TOF-Guard; Organon Teknika, BV, NL). The acceleromyographic transducer was placed on the volar aspect of the thumb, over the interphalangeal joint. The position of the transducer was secured by placing the thumb in the Hand Adapter (Organon International Inc., Roseland, NJ). The autocalibration (auto II mode) of single twitch to 100% was obtained prior to administering the priming dose. The technique was explained to all patients who cooperated and tolerated awake nerve stimulation. Neuromuscular blockade was measured by the response to single twitch stimuli at 0.1 Hz until maximal twitch depression was reached. The time period between injection of the intubating dose of rocuronium until suppression of the twitch tension to 95% of its control value was recorded and regarded as onset time. Suppression of neuromuscular function at 30, 60, and 90 seconds from rocuronium injection was also recorded.
Patients were randomly allocated, by computer-generated randomization sequence, to four groups of 15 patients each. Either S-ketamine (1 mg/kg) or thiopentone (4 mg/kg) was used for induction of anaesthesia with and without priming. Blinding was maintained by the use of sham priming in the two control groups where priming was not used. Hence the groups were: ketamine and priming (K+P), thiopentone and priming (T+P), ketamine and sham priming (K+0), and thiopentone and sham priming (T+0). The induction agents were injected over 30 seconds followed by the intubating dose of rocuronium given over five seconds. A diagram of the procedure is presented in Figure 1 . For blinding purposes induction agents were injected using similar syringes.
In the ketamine groups (K+P and K+0) ketamine was administered by a 2.5 ml syringe and normal saline by a 20 ml syringe, in the thiopentone groups (T+P and T+0) normal saline was administered by a 2.5 ml syringe and thiopentone by a 20 ml. Syringes were covered to prevent identification of the injected volumes in all of the four groups. The priming technique consisted of a priming dose of 0.04 mg/kg of rocuronium followed three minutes later by an intubating dose of 0.40 mg/kg of rocuronium. Prior to administering the priming dose patients were preoxygenated for five minutes. During the priming interval the patients continued oxygen inhalation and were closely monitored for signs of discomfort, palpebral ptosis, diplopia or respiratory difficulty. The patients were specifically asked about the possible symptoms over this interval of time. Orotracheal intubation was attempted 30 seconds after the intubating dose of rocuronium and was considered successful only if performed within 20 seconds from the start of laryngoscopy to inflation of the endotracheal cuff ( Figure 1 ). In the control groups, the same protocol was applied except that sham priming was performed by injection of normal saline followed three minutes after by a single intubating dose of 0.44 mg/kg of rocuronium. Tracheal intubation was performed within 50 seconds from the intubation dose and assessed by an anaesthesiologist with at least 10 years of clinical experience, who was blinded to the group allocation and not involved in the protocol. Intubating conditions were graded according to the criteria listed in Table 1 2 . Excellent and good conditions were considered clinically acceptable. The patients who could not be intubated within the 20 seconds interval were intubated once maximal blockade was achieved.
Non-invasive blood pressure and heart rate were recorded at baseline and every minute for the five minutes that followed intubation. On postoperative day one, patients were questioned for perception of any discomfort during the priming interval.
Statistical Analysis
Differences among groups were analysed by means of the nonparametric Kruskal Wallis test, followed, where significant, by the Mann Whitney U test. For normally distributed data the differences among groups were evaluated by ANOVA with an appropriate post hoc test for multiple comparisons. Results were considered significant at a value of P<0.05.
RESULTS
All groups were comparable with respect to age, weight, height and sex ratio ( Table 2) . Haemodynamic measurements before induction of anaesthesia and after intubation did not differ significantly among groups ( Table 3) .
Ketamine with priming presented intubating conditions graded good to excellent in 87% of patients, in contrast to only 26% of the T+P group (P<0.05 vs K+P group; Figure 2A ). In the K+P group the airway was secured in all patients within 20 seconds, whereas in 13% of the T+P group intubation was not possible within the allocated time (P<0.05). In control groups, without priming, intubating conditions were graded good to excellent in 20% of patients in the K+0 group, whereas only in 7% of cases in the T+0 group (P<0.05; Figure 2B ). Intubation was not possible within the allocated time in 53%, and 73% of patients respectively of K+0 and T+0 group; such rates are statistically significantly different when compared to their respective priming groups (P<0.05; Figures 2A and B Values are presented as mean±SD.
and 90 seconds after the intubating dose of rocuronium, as well as the onset time, was similar among all groups (Table 4 ). During the priming interval, no signs of patient discomfort, palpebral ptosis, blurred vision, respiratory difficulty or hypoxia were observed or reported. Moreover, there were no cases of delayed emergence from anaesthesia in the ketamine groups.
DISCUSSION
The present study supports the evidence that keta-mine and priming improve intubating conditions. As anticipated, the combination of ketamine and priming further improved clinical intubating conditions compared to the use of thiopentone and priming or ketamine without priming. Priming consisted of a subparalysing dose of 0.04 mg/kg of rocuronium, followed three minutes later by an intubating dose of 0.4 mg/kg of rocuronium. No signs of muscle impairment were detected, including no evidence of respiratory difficulty, during the priming interval. Unexpectedly, onset time, as measured by acceleromyography of the adductor pollicis muscle, was not reduced, despite the clinical improvement in intubating conditions. The onset time of rocuronium is significantly shorter than equivalent doses of other neuromuscular blocking agents 11 . Intubating conditions and onset times comparable to succinylcholine can be achieved with rocuronium only with the administration of 0.9 to 1.2 mg/kg, which can significantly increase the duration of action 4 .
Several studies support the hypothesis that ketamine improves orotracheal intubating conditions. Ledowski and co-workers 12 demonstrated that intubating conditions are significantly improved 60 seconds after 0.6 mg/kg of rocuronium when inducing anaesthesia with a combination of ketamine-etomidate compared to fentanyl-etomidate or placebo-etomidate. Hans and co-workers 8 and Baraka and co-workers 13 also reported better clinical intubating conditions with ketamine compared to thiopentone. Our results are consistent with those studies, as, in the control, without priming, groups of our study, ketamine did reduce the rate of failure to intubate within the allocated time compared to thiopentone ( Figure 2B ).
The onset time of muscle relaxants appears to be influenced by haemodynamic conditions 7 . Variables such as cardiac output, mean arterial pressure, and muscle blood flow may be responsible for promoting a faster delivery of neuromuscular blocking agents to the neuromuscular junction. Accordingly a combination of propofol and ephedrine for induction of anaesthesia provides significantly better intubating conditions than propofol alone when followed by rocuronium 14 . Ezri and co-workers 15 suggested that the significant reduction or prolongation of the onset time of rocuronium observed in patients pretreated respectively with ephedrine or esmolol may be secondary to changes in cardiac output produced by these drugs. Cardiac output was measured by Non Invasive Cardiac Output monitor (NICO™).
Although we expected significant differences in the haemodynamic profile between ketamine and thiopentone groups, we did not detect any significant differences. We measured haemodynamics at baseline and after intubation but not between these points because of the short interval between intubating dose and laryngoscopy and the non-invasive methods used.
Since it has been suggested that ketamine improves intubating conditions by promoting a faster delivery of neuromuscular blocking agents to their site of action, then haemodynamic measurements performed prior to attempting intubation may have detect differences which would have been missed with our protocol. Hans and co-workers 8 , who did perform such measurements immediately prior to intubation, observed significant increases in blood pressure with ketamine compared to thiopentone. The two anaesthetic agents differ in their mechanism of action, hence making it difficult to determine equipotent doses. Induction doses of thiopentone and ketamine varied among the studies of Hans and co-workers 8 , Baraka and co-workers 13 and our study (4 mg/kg thiopentone and 1.5 mg/kg ketamine, 5 mg/kg thiopentone and 2.5 mg/kg ketamine, and 4 mg/kg thiopentone and 1 mg/kg of S-ketamine respectively). The results and conclusions were similar in all these studies. The better intubating con- ditions observed with ketamine in our study may yet be partially explained by the sympathomimetic effects of ketamine which result in increased cardiac output and tissue perfusion, and consequently in faster delivery of rocuronium to the laryngeal muscles. Validation of this hypothesis would require measurements of cardiac output and muscle blood flow during the brief interval between the induction of anaesthesia and laryngoscopy. The divided dose technique of administration of nondepolarizing muscle relaxants for facilitation of rapid tracheal intubation is based on the high margin of safety of neuromuscular transmission that allows 70 to 75% occupancy of the cholinergic receptors without any significant effect on neuromuscular activity 5 . The administration of the second larger dose of a muscle relaxant, at the time of peak effect of the priming dose, will rapidly increase receptor occupancy to the 90-92% level required for profound neuromuscular block 5 . During the relatively long priming interval, the conscious patient may suffer from distressing symptoms of muscle weakness such as blurred vision, dysphagia, and respiratory embarrassment 16 . The size of the priming and intubating doses, as well as the priming interval are therefore crucial in the efficacy of the priming technique and in the reduction of the incidence of such adverse effects 17 .
Priming with rocuronium has been investigated in several studies, showing a reduction in onset time 6, 18, 19 . Naguib and colleagues 6 demonstrated that 0.06 mg/kg of rocuronium (20% ED 95 ) followed three minutes later by 0.54 mg/kg reduces the onset time by approximately 20 to 35%, compared to a single intubation dose of 0.6 mg/kg of rocuronium. In the present investigation, we selected a lower priming and intubating dose of rocuronium, a priming interval of three minutes, and intubation was attempted 30 seconds after the intubating dose of rocuronium to make detection of the possible effects of ketamine on priming more likely. We demonstrated that the combination of priming and ketamine markedly improved intubating conditions, despite there being no significant change in onset time.
The rationale of combining the priming principle with ketamine consists in the partial occupancy of the cholinergic receptors by the priming dose and the acceleration by ketamine of the residual receptor occupancy once the intubating dose of neuromuscular blocker is administered, hence further reducing time for clinically acceptable intubating conditions. Additional beneficial effects of ketamine on intubating conditions may be secondary to its potent anal-gesic properties and its effect on blunting airway reflexes. Whereas similar mechanisms have been proposed to justify the improved intubating conditions observed with ketamine, thiopentone in contrast may exaggerate the airway reflexes and promote coughing and laryngospasm 8 .
Consistent with the observations of Hans and colleagues 8 and Baraka and colleagues 13 the degree of neuromuscular block of the adductor pollicis measured at the time of intubation was similar among the groups. Likewise, suppression of twitch tension at 30, 60, and 90 seconds after the intubating dose of rocuronium did not differ among groups regardless of the induction agent or the use of the priming principle. Such an apparent discrepancy can be explained by the different intrinsic sensitivities to muscle relaxants of different muscle groups such as the adductor pollicis, the laryngeal and the respiratory muscles. Meistelman and co-workers 20 documented a more rapid onset of action of rocuronium at the larynx than at the adductor pollicis, while in the study by Wright and co-workers 21 , such a relationship was observed only after 0.4 mg/kg of rocuronium but not after 0.8 or 1.2 mg/kg. Kopman and co-workers 22 demonstrated that excellent intubating conditions, 75 seconds after 0.5 mg/kg of rocuronium, did not correspond to comparable effects on twitch response measured at the adductor pollicis. Such results were in accordance with those initially described by Agoston 23 and subsequently advised by the Copenhagen international consensus conference on good clinical research practice 24 : "Intubation conditions and paralysis of the adductor pollicis muscle may be poorly correlated and complete paralysis of this muscle may be a poor indicator of intubation time or of the time to evaluate intubation conditions."
The early enthusiasm for priming as a clinically useful method has been tempered with time due to the risk of adverse effects during the priming interval. Musich and colleagues 25 reported a case of pulmonary aspiration after a priming dose of 0.02 mg/kg of vecuronium (40% of ED 95 ), whereas Aziz and colleagues 26 described decreases in haemoglobin oxygen saturation and pulmonary function in elderly patients during the priming interval using a dose of 0.01 mg/kg of vecuronium (20% of ED 95 ). In a theoretical analysis of safety and timing of the priming dose, Kopman and co-workers 27 concluded that a dose equivalent to 10% of ED 95 will rarely produce a measurable neuromuscular effect. The studies reporting adverse effects did involve higher priming doses. In several studies of rocuronium even with larger priming doses, ranging between 0.06 and 0.1 mg/kg (20-33% of ED 95 ), no adverse effects were reported during the priming interval 6, 19, 28 . In the present investigation we selected a priming dose of little more than 10% of ED 95 which probably accounted for the absence of both subjective and clinical adverse effects during the priming interval.
The possible clinical utility of our findings requires further assessment.
In conclusion, ketamine and priming both improved clinical intubating conditions when compared with the use of thiopentone or no priming. The combination of ketamine and priming results in further improvement in clinical intubating conditions compared with ketamine without priming and with thiopentone with or without priming. Ketamine and priming did not reduce the onset time as measured by acceleromyography of the adductor pollicis.
